GSA Capital Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.13M | Sell |
|
|||||
|
2025
Q2 | $814K | Sell |
|
|||||
|
2025
Q1 | $423K | Buy |
|
|||||
|
2024
Q4 | $205K | Buy |
|
|||||
|
2024
Q3 | $84K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $19K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $55K | Sell |
|
|||||
|
2022
Q2 | $187K | Buy |
|
|||||
|
2022
Q1 | $112K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $188K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $13K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $359K | Sell |
|
|||||
|
2017
Q3 | $496K | Buy |
|
|||||
|
2017
Q2 | $246K | Buy |
|